NasdaqCM - Nasdaq Real Time Price USD

Compass Therapeutics, Inc. (CMPX)

2.1500
+0.0500
+(2.38%)
At close: June 2 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
850
850
0
0
0
Operating Expense
62,671
57,475
50,363
41,655
31,264
Operating Income
-61,821
-56,625
-50,363
-41,655
-31,264
Net Non Operating Interest Income Expense
1,031
7,300
7,900
2,360
-341
Other Income Expense
-700
-50
-31
70
-50,576
Pretax Income
-55,221
-49,375
-42,494
-39,225
-82,181
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-55,221
-49,375
-42,494
-39,225
-82,181
Diluted NI Available to Com Stockholders
-55,221
-49,375
-42,494
-39,225
-82,181
Basic EPS
-0.40
--
-0.33
-0.37
-1.31
Diluted EPS
-0.40
--
-0.33
-0.37
-1.31
Basic Average Shares
137,791
--
127,027
105,186
62,870
Diluted Average Shares
137,791
--
127,027
105,186
62,870
Total Operating Income as Reported
-61,821
-56,625
-50,363
-41,655
-81,882
Total Expenses
62,671
57,475
50,363
41,655
31,264
Net Income from Continuing & Discontinued Operation
-55,221
-49,375
-42,494
-39,225
-82,181
Normalized Income
-55,221
-49,375
-42,494
-39,295
-31,605
Interest Income
1,070
7,300
7,900
2,360
29
Interest Expense
39
--
--
0
370
Net Interest Income
1,031
7,300
7,900
2,360
-341
EBIT
-61,821
-56,625
-50,363
-41,655
-81,811
EBITDA
-60,167
-54,872
-48,473
-39,751
-80,187
Reconciled Depreciation
1,654
1,753
1,890
1,904
1,624
Net Income from Continuing Operation Net Minority Interest
-55,221
-49,375
-42,494
-39,225
-82,181
Total Unusual Items Excluding Goodwill
112
--
0
70
-50,576
Total Unusual Items
112
--
0
70
-50,576
Normalized EBITDA
-60,167
-54,872
-48,473
-39,821
-29,611
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CNTX Context Therapeutics Inc.
0.5880
+1.89%
 
RZLT Rezolute, Inc.
4.2250
+2.55%
 
BOLD Boundless Bio, Inc.
1.1300
+2.73%
 
LSTA Lisata Therapeutics, Inc.
2.7400
+4.97%
 
ERNA Ernexa Therapeutics Inc.
0.2190
+0.46%
 
QNCX Quince Therapeutics, Inc.
1.0600
+1.92%
 
VTVT vTv Therapeutics Inc.
16.54
+4.09%
 
ACRV Acrivon Therapeutics, Inc.
1.1100
+5.71%
 
ERAS Erasca, Inc.
1.4250
+1.79%
 
GHRS GH Research PLC
11.56
-3.91%